Sign inJoin waitlistJoin the waitlist

RP

Robert Provenzano

Nephrology

Credentials: · · · · · · · · · · ·

History

Nephrology
Internal Medicine

Research

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Nephrology · 2015 · 243 citations
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
Clinical Journal of the American Society of Nephrology · 2016 · First of 16 authors · 231 citations
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator,…
American Journal of Kidney Diseases · 2016 · First of 13 authors · 220 citations

AB
Anatole Besarab
7 papers
Lynda Szczech
6 papers
Andrew Levey
5 papers
SA
Sharon Andreoli
5 papers
Thomas DuBose
5 papers
JT
Jukaku Tayeb
4 papers
QK
Quresh Khairullah
4 papers
RZ
Raja Zabaneh
4 papers
SF
Steven Fishbane
4 papers
AN
Allen Nissenson
2 papers
KB
Keith Bellovich
2 papers
KY
Kin-Hung Yu
2 papers